Can the Consideration of Societal Costs Change the Recommendation of Economic Evaluations in the Field of Rare Diseases? An Empirical Analysis

1. Aranda-Reneo, I.
2. Rodríguez-Sánchez, B.
3. Peña-Longobardo, L.M.
4. Oliva-Moreno, J.
5. López-Bastida, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.JVAL.2020.10.014 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus